UCB PHARMA SA

UCB PHARMA SA logo
🇧🇪Belgium
Ownership
Public, Subsidiary
Established
1928-01-01
Employees
9K
Market Cap
$34.9B
Website
https://www.ucb-iberia.com/home

Efficacy and Safety of CDP870 and Methotrexate Compared to Methotrexate Alone in Subjects With Rheumatoid Arthritis

Phase 3
Completed
Conditions
First Posted Date
2007-10-16
Last Posted Date
2013-09-04
Lead Sponsor
UCB Pharma
Target Recruit Count
247
Registration Number
NCT00544154

Efficacy and Safety of Levocetirizine and Fexofenadine in Reducing Symptoms of Seasonal Allergic Rhinitis

Phase 4
Completed
Conditions
First Posted Date
2007-10-11
Last Posted Date
2013-12-12
Lead Sponsor
UCB Pharma
Target Recruit Count
94
Registration Number
NCT00542607

Open-label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy

Phase 2
Completed
Conditions
Interventions
First Posted Date
2007-09-26
Last Posted Date
2011-08-31
Lead Sponsor
UCB Pharma
Target Recruit Count
33
Registration Number
NCT00535392

Trial to Assess Long-term Lacosamide (LCM) Monotherapy Use and Safety of LCM Monotherapy and Adjunctive Therapy for Partial-onset Seizures

Phase 3
Completed
Conditions
Interventions
First Posted Date
2007-09-18
Last Posted Date
2018-07-18
Lead Sponsor
UCB Pharma
Target Recruit Count
322
Registration Number
NCT00530855
Locations
🇺🇸

137, Waldorf, Maryland, United States

🇺🇸

094, Doral, Florida, United States

🇺🇸

029, Scarborough, Maine, United States

and more 105 locations

Efficacy and Safety of Levocetirizine Versus Loratadine for the Treatment of Perennial Allergic Rhinitis

Phase 3
Completed
Conditions
First Posted Date
2007-09-05
Last Posted Date
2013-12-16
Lead Sponsor
UCB Pharma
Target Recruit Count
71
Registration Number
NCT00524836

To Evaluate the Efficacy and Safety of Levocetirizine Versus Loratadine for Treatment of Seasonal Allergic Rhinitis

Phase 3
Completed
Conditions
First Posted Date
2007-09-05
Last Posted Date
2013-12-16
Lead Sponsor
UCB Pharma
Target Recruit Count
67
Registration Number
NCT00525278

Study to Compare the Efficacy and Safety Between Levocetirizine and Loratadine for Chronic Idiopathic Urticaria

Phase 3
Completed
Conditions
First Posted Date
2007-09-05
Last Posted Date
2013-12-12
Lead Sponsor
UCB Pharma
Target Recruit Count
134
Registration Number
NCT00525382

Naturalistic Study to Evaluate the Utilization of Care Services Associated to the Diagnostic Process of Any Kind of Epilepsy

Completed
Conditions
First Posted Date
2007-08-29
Last Posted Date
2012-05-30
Lead Sponsor
UCB Pharma
Target Recruit Count
400
Registration Number
NCT00522522
Locations
🇺🇸

UCB Pharma, Smyrna, Georgia, United States

Trial to Assess Parkinson's Disease (PD) Symptom Control to Four Doses of Rotigotine in a Transdermal Patch

Phase 3
Completed
Conditions
Interventions
First Posted Date
2007-08-29
Last Posted Date
2014-10-27
Lead Sponsor
UCB Pharma
Target Recruit Count
514
Registration Number
NCT00522379

Evaluation of Efficacy and Safety of Levocetirizine to Subjects With Perennial Allergic Rhinitis to House Dust Mites

Phase 4
Completed
Conditions
First Posted Date
2007-08-27
Last Posted Date
2013-12-16
Lead Sponsor
UCB Pharma
Target Recruit Count
453
Registration Number
NCT00521131
© Copyright 2024. All Rights Reserved by MedPath